Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6716782 | 1.00 | MEN1 (0.40) | MEN1KMT2ADNM1ALDH1A1CYP1A2 | |
| SCHEMBL5964912 | 1.00 | MEN1 (0.40) | MEN1KMT2ADNM1ALDH1A1CYP1A2 | |
| SCHEMBL6542019 | 1.00 | MEN1 (0.40) | MEN1KMT2ADNM1ALDH1A1CYP1A2 | |
| SCHEMBL1669437 | 1.00 | MEN1 (0.40) | MEN1KMT2ADNM1ALDH1A1CYP1A2 | |
| SCHEMBL96871 | 1.00 | MEN1 (0.40) | MEN1KMT2ADNM1ALDH1A1CYP1A2 | |
| SCHEMBL6717183 | 1.00 | MEN1 (0.40) | MEN1KMT2ADNM1ALDH1A1CYP1A2 | |
| SCHEMBL96272 | 0.98 | LTA4H (0.38) | MEN1KMT2ADNM1ALDH1A1CYP1A2 | |
| SCHEMBL49576 | 0.91 | LTA4H (0.38) | MEN1KMT2AALDH1A1SMN1; SMN2CES2 | |
| SCHEMBL95534 | 0.81 | ALDH1A1 (0.41) | MEN1KMT2AALDH1A1TP53MAPK1 | |
| Azobenzene SCHEMBL27918792 | 0.79 | ALDH1A1 (0.60) | MEN1KMT2ADNM1ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7723522-B2 | Pyridine derivative production method | FUJIFILM FINECHEMICALS CO., LTD (JP) | 2010-05-25 | — | — | US | disclosed |
| EP-1559711-B1 | PREPARATION OF PYRIDINE DERIVATIVES USING PYRIMIDINIUM DERIVATIVES AS INTERMEDIATES | FUJIFILM FINECHEMICALS CO LTD (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-6926943-B2 | Use of light-absorbing compounds in the information layer of optical data carriers, and optical data carriers | BAYER AKTIENGESELLSCHAFT (DE) | 2005-08-09 | — | — | US | disclosed |
| US-20050171355-A1 | Pyridine derivative production method | SANKIO CHEMICAL CO., LTD. | 2005-08-04 | — | — | US | disclosed |
| EP-1559711-A1 | PREPARATION OF PYRIDINE DERIVATIVES USING PYRIMIDINIUM DERIVATIVES AS INTERMEDIATES | Sankio Chemical Co., Ltd. (JP) | 2005-08-03 | — | — | EP | disclosed |
| EP-1452574-A1 | COMPOSITION FOR ORGANIC ELECTROLUMINESCENCE ELEMENT AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME | TOYO INK MFG. CO., LTD. (JP) | 2004-09-01 | — | — | EP | disclosed |
| US-20040151944-A1 | Anode, cathode, light emitting layers | TOYO INK MFG. CO., LTD. (JP) | 2004-08-05 | — | — | US | disclosed |
| EP-0900790-B1 | Triazine dithiol derivatives having a perfluoro group for treating metal surfaces | UNIV IWATE (JP) | 2004-06-23 | — | — | EP | disclosed |
| US-20030175616-A1 | Optical recording media; high density writing | LANXESS DEUTSCHLAND GMBH (DE) | 2003-09-18 | — | — | US | disclosed |
| US-6117893-A | Heterocyclic compounds having anti-diabetic activity and their use | SANKYO COMPANY, LIMITED (JP) | 2000-09-12 | — | — | US | disclosed |
| EP-0900790-A1 | Triazine thiol derivatives having a perfluoro group for treating metal surfaces | Iwate University (JP) | 1999-03-10 | — | — | EP | disclosed |
| US-5834501-A | TREATING DIABETES OR HYPERLIPEMIA | SANKYO COMPANY, LIMITED (JP) | 1998-11-10 | — | — | US | disclosed |
| US-5739345-A | HYPOGLYCEMIC AND ANTIDIABETIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1998-04-14 | — | — | US | disclosed |
| US-5624935-A | ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS | SANKYO COMPANY, LIMITED | 1997-04-29 | — | — | US | disclosed |
| EP-0597287-B1 | Process for the preparation of anthraquinones | BASF AG (DE) | 1996-04-10 | — | — | EP | disclosed |
| EP-0676398-A2 | Heterocyclic compounds having anti-diabetic activity, their preparation and their use | SANKYO COMPANY LIMITED (JP) | 1995-10-11 | — | — | EP | disclosed |
| US-5429918-A | Antifading agent | FUJI PHOTO FILM CO., LTD. (JP) | 1995-07-04 | — | — | US | disclosed |
| US-5387704-A | Preparation of anthraquinones | BASF AKTIENGESELLSCHAFT (DE) | 1995-02-07 | — | — | US | disclosed |
| EP-0597287-A1 | Process for the preparation of anthraquinones | BASF Aktiengesellschaft (DE) | 1994-05-18 | — | — | EP | disclosed |
| US-4353734-A | PRE- AND POSTEMERGENCE | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA R.T. (HU) | 1982-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171355-A1 | Pyridine derivative production method | CPS1, NAT1, ACMSD | MEN1 1682/4885KMT2A 1451/4885DNM1 680/4885 |
| US-20030175616-A1 | Optical recording media; high density writing | RHOA, IK, YTHDF1 | MEN1 2318/4885KMT2A 165/4885DNM1 1563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.